Indian Pharmacopoeia Commission Flags Adverse Drug Reaction Linked To Mefenamic Acid. The Indian Pharmacopoeia Commission (IPC) has issued a drug safety alert for November, revealing a potential link between Mefenamic Acid, a non-steroidal anti-inflammatory agent prescribed for mild to moderate pain and primary dysmenorrhea, and adverse drug reactions (ADRs) related to Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome. The alert, based on a preliminary analysis of Adverse Dr